tiprankstipranks
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
Holding GLMD?
Track your performance easily

Galmed Pharmaceuticals (GLMD) Financial Statements

1,262 Followers

Galmed Pharmaceuticals Financial Overview

Galmed Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-12.037; its P/E ratio is -0.25; Galmed Pharmaceuticals is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT--$ -5.38M$ -3.73M$ -6.09M
EBITDA--$ -5.37M$ -3.72M$ -6.08M
Net Income Common Stockholders--$ -5.35M$ -3.73M$ -6.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.11M$ 13.90M$ 19.21M$ 22.40M$ 28.74M
Total Assets$ 16.63M$ 16.56M$ 20.87M$ 23.57M$ 30.20M
Total Debt$ 41.00K$ 578.00K$ 89.00K$ 134.00K$ 183.00K
Net Debt$ -5.07M$ -13.32M$ -19.12M$ -22.27M$ -28.56M
Total Liabilities$ 2.75M$ 3.14M$ 5.12M$ 2.86M$ 5.83M
Stockholders Equity$ 13.88M$ 13.42M$ 15.75M$ 20.71M$ 24.37M
Cash Flow-
Free Cash Flow--$ -3.11M$ -5.91M$ -5.45M
Operating Cash Flow--$ -3.11M$ -5.91M$ -5.45M
Investing Cash Flow--$ 5.13M$ 4.15M$ 6.31M
Financing Cash Flow--$ 70.00K$ 0.00$ 0.00
Currency in USD

Galmed Pharmaceuticals Earnings and Revenue History

Galmed Pharmaceuticals Debt to Assets

Galmed Pharmaceuticals Cash Flow

Galmed Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis